Previous 10 |
home / stock / mdgef / mdgef news
The following slide deck was published by Medigene AG in conjunction with their 2018 Q4 earnings Read more ...
Medigene AG ( OTCPK:MDGEF ): FY GAAP EPS of -€0.72. Revenue of €7.75M (-12.7% Y/Y) Press Release More news on: Medigene AG, Earnings news and commentary, Tech stocks news, ,
February was a very turbulent month for me. Although the markets rallied strongly the earnings season, as always, has been a wild one and a painful one as well for a few stocks. On top of that, high-flying German fintech Wirecard (WCAGY) (WRCDF) completely collapsed following allegations about...
2019 started with a big rally. Following an initial slump, markets rose throughout the month as optimism regarding the outcome of China-U.S trade negotiations, a better-than-expected earnings season and a less hawkish Fed have provided lots of fuel. (Source: onvista.de - Dow Jones Last 3M )...
News, Short Squeeze, Breakout and More Instantly...
Planegg/Martinsried, July 23, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today announced the presentation of two posters...
Planegg/Martinsried, July 3, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announces today that the Company has been issued...
Planegg/Martinsried, June 27, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today provides a detailed overview of its lead ...